EUVIMEDEUVIMED entdecken
Crossref

Proceedings of the 2023 Annual Scientific Meeting of the French Society of Toxicologic Pathology (SFPT) on Preclinical Development and Therapeutic Applications of mRNA-Based Technologies

Pierluigi Fant iD, Sébastien Laurent, Paul Desert, Behazine Combadière, Xavier Palazzi iD, Shambhunath Choudhary iD, Frédéric Gervais, Karine Broudic, Roberta Rossi, Béatrice E Gauthier iD

Toxicologic Pathology · 2025

DOI: 10.1177/01926233251326089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicologic Pathology, 2025. Verfasst von Pierluigi Fant und 9 weiteren Autor:innen. Beteiligte Einrichtung: Charles River Laboratories Safety Assessment, Saint Germain-Nuelles, France. Hauptthemen laut MEDLINE: RNA, Messenger, COVID-19 Vaccines. Die Arbeit nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 2023 annual scientific meeting of the French Society of Toxicologic Pathology (Société Française de Pathologie Toxicologique, SFPT), entitled “mRNA-based technologies: preclinical development and therapeutic applications,” was held in Lyon (France) on May 25 to 26, 2023. The aim of the meeting was to discuss the biology, immunology, and preclinical development of messenger RNA (mRNA)-based vaccines and therapeutics, including immuno-oncology and rare diseases, as well as the regulatory aspect of the COVID-19 vaccines and an overview of the principles and applications of in situ hybridization techniques. This article presents the summary of five lectures along with selected figures, tables, and key literature references on this topic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, MessengerCOVID-19 VaccinesHumansAnimalsFranceCOVID-19SARS-CoV-2ToxicologyDrug Evaluation, Preclinical

Stichwörter der Autor:innen

SFPT annual meetingmRNAregulatoryvaccine

Substanzen

RNA, MessengerCOVID-19 Vaccines

Autor:innen und Institutionen

  • Charles River Laboratories Safety Assessment, Saint Germain-Nuelles, France.
  • Sanofi, Montpellier, France.
  • Sanofi Vaccine R&D, Marcy-l'Étoile, France.
  • Pfizer Inc, Groton, Connecticut, USA.
  • Pfizer Inc, Pearl River, New York, USA.
  • Charles River Laboratories, Evreux, France.

ORCID-Profile: Pierluigi Fant, Xavier Palazzi, Shambhunath Choudhary, Béatrice E Gauthier

Zitieren

APA

Fant, P., Laurent, S., Desert, P., Combadière, B., Palazzi, X., Choudhary, S., Gervais, F., Broudic, K., Rossi, R., & Gauthier, B. E. (2025). Proceedings of the 2023 Annual Scientific Meeting of the French Society of Toxicologic Pathology (SFPT) on Preclinical Development and Therapeutic Applications of mRNA-Based Technologies. Toxicologic Pathology. https://doi.org/10.1177/01926233251326089

Vancouver

Fant P, Laurent S, Desert P, Combadière B, Palazzi X, Choudhary S, et al. Proceedings of the 2023 Annual Scientific Meeting of the French Society of Toxicologic Pathology (SFPT) on Preclinical Development and Therapeutic Applications of mRNA-Based Technologies. Toxicologic Pathology. 2025. doi:10.1177/01926233251326089

BibTeX
@article{Fant2025,
  author = {Fant, Pierluigi and Laurent, Sébastien and Desert, Paul and Combadière, Behazine and Palazzi, Xavier and Choudhary, Shambhunath and Gervais, Frédéric and Broudic, Karine and Rossi, Roberta and Gauthier, Béatrice E},
  title = {Proceedings of the 2023 Annual Scientific Meeting of the French Society of Toxicologic Pathology (SFPT) on Preclinical Development and Therapeutic Applications of mRNA-Based Technologies},
  journal = {Toxicologic Pathology},
  year = {2025},
  doi = {10.1177/01926233251326089}
}
Kostenlos starten →